key: cord-0857145-cgdjtyaj
authors: Hulsebus, Holly J.; Najarro, Kevin M.; McMahan, Rachel H.; Boe, Devin M.; Orlicky, David J.; Kovacs, Elizabeth J.
title: Ethanol Intoxication Impairs Respiratory Function and Bacterial Clearance and Is Associated With Neutrophil Accumulation in the Lung After Streptococcus pneumoniae Infection
date: 2022-05-04
journal: Front Immunol
DOI: 10.3389/fimmu.2022.884719
sha: 9137ee32d12188674a4eb095c3a390c1e602289a
doc_id: 857145
cord_uid: cgdjtyaj

Alcohol consumption is commonplace in the United States and its prevalence has increased in recent years. Excessive alcohol use is linked to an increased risk of infections including pneumococcal pneumonia, mostly commonly caused by Streptococcus pneumoniae. In addition, pneumonia patients with prior alcohol use often require more intensive treatment and longer hospital stays due to complications of infection. The initial respiratory tract immune response to S. pneumoniae includes the production of pro-inflammatory cytokines and chemokines by resident cells in the upper and lower airways which activate and recruit leukocytes to the site of infection. However, this inflammation must be tightly regulated to avoid accumulation of toxic by-products and subsequent tissue damage. A majority of previous work on alcohol and pneumonia involve animal models utilizing high concentrations of ethanol or chronic exposure and offer conflicting results about how ethanol alters immunity to pathogens. Further, animal models often employ a high bacterial inoculum which may overwhelm the immune system and obscure results, limiting their applicability to the course of human infection. Here, we sought to determine how a more moderate ethanol exposure paradigm affects respiratory function and innate immunity in mice after intranasal infection with 10(4) colony forming units of S. pneumoniae. Ethanol-exposed mice displayed respiratory dysfunction and impaired bacterial clearance after infection compared to their vehicle-exposed counterparts. This altered response was associated with increased gene expression of neutrophil chemokines Cxcl1 and Cxcl2 in whole lung homogenates, elevated concentrations of circulating granulocyte-colony stimulating factor (G-CSF), and higher neutrophil numbers in the lung 24 hours after infection. Taken together, these findings suggest that even a more moderate ethanol consumption pattern can dramatically modulate the innate immune response to S. pneumoniae after only 3 days of ethanol exposure and provide insight into possible mechanisms related to the compromised respiratory immunity seen in alcohol consumers with pneumonia.

Alcohol consumption is commonplace in the United States and its prevalence has increased in recent years. Excessive alcohol use is linked to an increased risk of infections including pneumococcal pneumonia, mostly commonly caused by Streptococcus pneumoniae. In addition, pneumonia patients with prior alcohol use often require more intensive treatment and longer hospital stays due to complications of infection. The initial respiratory tract immune response to S. pneumoniae includes the production of pro-inflammatory cytokines and chemokines by resident cells in the upper and lower airways which activate and recruit leukocytes to the site of infection. However, this inflammation must be tightly regulated to avoid accumulation of toxic by-products and subsequent tissue damage. A majority of previous work on alcohol and pneumonia involve animal models utilizing high concentrations of ethanol or chronic exposure and offer conflicting results about how ethanol alters immunity to pathogens. Further, animal models often employ a high bacterial inoculum which may overwhelm the immune system and obscure results, limiting their applicability to the course of human infection. Here, we sought to determine how a more moderate ethanol exposure paradigm affects respiratory function and innate immunity in mice after intranasal infection with 10 4 colony forming units of S. pneumoniae. Ethanol-exposed mice displayed respiratory dysfunction and impaired bacterial clearance after infection compared to their vehicle-exposed counterparts. This altered response was associated with increased gene expression of neutrophil chemokines Cxcl1 and Cxcl2 in whole lung homogenates, elevated concentrations of circulating granulocyte-colony stimulating factor (G-CSF), and higher

The immune system is influenced by a myriad of environmental factors, including alcohol consumption. In 2019, 69% of U.S. adults aged 26 years or older reported alcohol use in the past month (1) . Importantly, social stresses associated with the COVID-19 pandemic have led to increased sales of alcoholic beverages: sales were 3.6% higher in March 2020 and 15.5% higher in April 2021 when compared to a 3-year average from the same month in 2017-2019 (2) . Further, alcohol-related deaths have been rising at an astonishingly quick pace in recent years: fatalities due to alcohol rose by 25.9% between 2019 and 2020, compared to a 16.6% increase in age-adjusted mortality rates from all causes (3) . Based on this rapidly escalating prevalence of alcohol consumption, we will likely continue to see a rise alcohol-associated morbidity and mortality well into the future.

Alcohol's effects on the immune system vary based on the amount and duration of consumption. Broadly speaking, alcohol intake can be classified as "moderate" or "excessive" (4). The U.S. Centers for Disease Control and Prevention describe "moderate" alcohol intake as 1-2 drinks per day for males or 1 drink per day for a female (4) . "Excessive" alcohol consumption includes binge drinking, or that which brings blood alcohol concentration (BAC) above the "legal limit" for driving (80 mg/dL; usually 5 + drinks for a male or 4+ drinks for a female within 2 hours) and heavy drinking, considered 14+ drinks per week for a male or 7+ drinks for a female (5) . In addition, human studies characterize "alcohol use disorder" (AUD) as the inability to modify or discontinue alcohol use despite adverse consequences to one's personal or work life, and is clinically measured by several social and psychological parameters (6) .

Epidemiological studies have shown that moderate alcohol intake is generally associated with protective health effects, such as decreased risk of cardiovascular disease [reviewed in (7)], lower concentrations of circulating inflammatory biomarkers (8) , and lower risk of all-cause mortality in humans (9) . In contrast, other studies have found an increased risk for all-cause mortality in adults with heavy alcohol consumption [> 14 and > 7 drinks per week for men and women, respectively (9), or 5+ drinks on a single occasion at least once per week in the past year (10) ]. Additionally, chronic alcohol users often have health complications associated with alcoholic hepatitis and its treatment, such as invasive aspergillosis (11) and infections of the lower respiratory and urinary tracts (12) . Mouse models have similarly shown that excessive ethanol exposure is linked to deleterious effects on immunity; these include decreased responsiveness to Toll-like receptor (TLR) 2, 4, and 9 agonists (13), diminished phagocytic capacity (14, 15) , impaired respiratory function (16) , and increased airway neutrophils following acute lipopolysaccharide-induced lung injury (17) . Neutrophil function is also compromised due to excessive ethanol consumption. For example, chronic ethanol exposure is associated with impaired neutrophil chemotaxis to the airways following pulmonary Aspergillus fumigatus infection, along with attenuated phagocytosis, fungal killing, and reactive oxygen species production in A. fumigatus-challenged neutrophils from ethanol-fed mice (18) . Others have demonstrated that acute ethanol treatment (6 g/kg) decreases neutrophil infiltration into the peritoneal cavity following cecal ligation and puncture, accompanied by diminished production of neutrophil extracellular traps and bacterial killing (19) .

Excessive alcohol use has been linked to increased susceptibility to infectious diseases such as pneumonia, with the most common bacterial cause being Streptococcus pneumoniae (20) . The estimated annual incidence of pneumonia in the United States is 24.8 cases per 10,000 adults (21) , and approximately 3.5% of pneumonia patients had an AUD at diagnosis (22) . In fact, meta-analyses have found a dosedependent, linear relationship between alcohol consumption and relative risk for contracting pneumonia (23, 24) . In addition, patients with alcohol use disorder are more likely to have severe invasive disease that requires hospitalization (25) and adults who drink excessively (> 60 grams per day) are 4 times more likely to die within 30 days of infection (26) .

Innate immune recognition of S. pneumoniae by tissueresident alveolar macrophages or epithelial cells stimulates the production of pro-inflammatory C-X-C motif chemokine ligand 1 (CXCL1) and CXCL2, which recruit and activate cells, such as monocytes, macrophages, and neutrophils to the site of infection (27) (28) (29) . Additionally, in the context of pulmonary injury, CXCL12 promotes neutrophil migration and retention in the lung (30, 31) . Important chemokines for the production and mobilization of granulocytes from the bone marrow are granulocyte colony stimulating factor (G-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF). Following an inflammatory stimuli such as infection, G-CSF and GM-CSF are rapidly produced and secreted by monocytes, macrophages, fibroblasts, and endothelial cells and this corresponds with an increase in neutrophil differentiation and production in the bone marrow (32) (33) (34) . Indeed, mice lacking G-CSF or its receptor have reduced neutrophil counts in the blood and bronchoalveolar lavage (BAL) fluid following Pseudomonas aeruginosa lung infection (35) . While the importance of innate immune cells in the response to S. pneumoniae has long been appreciated (36) (37) (38) , excessive accumulation of these cells can be deleterious to host tissue if the inflammatory response is not properly controlled. For example, increased neutrophil recruitment to the lungs following influenza-induced pneumonia in mice is associated with alveolar damage, pulmonary edema, and development of a phenotype similar to that seen in critically ill humans with acute respiratory distress syndrome (39) .

Our current knowledge regarding the effects of acute alcohol intoxication on lung immunity is largely based on animal studies using supra-physiologic doses of alcohol (3-5 g/kg) (40, 41) , sometimes high enough to raise blood alcohol concentration to 350-550 mg/dL (42, 43) . Here, we sought to determine the effect of a 3 day lower-dose alcohol regimen (1.5 g/kg; target BAC of 80 mg/dL) on the pulmonary response to a clinically relevant intranasal S. pneumoniae infection (44) .

Female BALB/cBy mice (Jackson Laboratory) were housed at the University of Colorado Anschutz Medical Campus in specific pathogen-free conditions for at least 2 weeks prior to the start of studies. Animals used in experiments were 3-5 months of age and weighed at least 20 grams. All animal experiments were performed under a protocol approved by the Institutional Animal Care and Use Committee at the University of Colorado Anschutz Medical Campus (protocol number 00087). Animals were housed in a temperature-(72°F ± 2°) and humidity-(35%) controlled room with a 14-hour light cycle (6am-8pm) and 10-hour dark cycle (8pm-6am), and provided with a nestlet for environmental enrichment. Experiments were performed between the hours of 8 and 10 am to minimize confounding effects of circadian variation in corticosterone and other hormones which can influence inflammatory and immune responses (45) . For these studies, 3-6 mice comprised each control or treatment group and results are combined from 2-3 individual experiments as indicated in the figure legends.

Mice were orally gavaged with a 20% v/v ethanol solution (1.5 g/kg based on body weight) or vehicle (sterile water) once daily for 3 consecutive days (46) . BAC levels were confirmed in each experiment by obtaining blood via tail snip at 30 minutes postgavage and analyzing ethanol levels in a 1:50 dilution of serum using a commercially available kit (BioVision K620). Animals were gavaged between 8 and 9 am to mimic human drinking patterns.

Previously frozen glycerol stocks (1 ml) of Streptococcus pneumoniae serotype 3 (ATCC 6303) were quickly thawed at 37°C, added to 4 ml of tryptic soy broth (BD 211825), and incubated statically at 37°C/5% CO 2 until the culture reached mid-log phase (47) . Bacteria were washed twice in sterile phosphate buffered saline (PBS), resuspended in an appropriate volume to yield approximately 10 4 colony forming units (CFU) in 50 µl, and kept on ice until inoculation. One hour after the final gavage, mice were anesthetized with an intraperitoneal injection of 12.5 mg/kg of ketamine and 1.25 mg/kg of xylazine (Webster Veterinary, Sterling, MA), and 50 ul of the prepared inoculum or sterile PBS (Gibco 14190-144) for sham animals was instilled trans-nasally. Mice were held vertically for 1 minute to assist inoculum draining into the lungs. Any mice losing more than 15% of their body weight were humanely euthanized and excluded from analysis. The exact dose of inoculum was quantified in each experiment by serial dilution of the bacterial suspension and plating on tryptic soy agar containing 5% sheep's blood (Remel R01200).

Respiratory function was measured in conscious mice using unrestrained whole-body barometric plethysmography (Buxco Research Systems) as described (16, 48) . Briefly, mice were allowed to acclimate in the sealed chamber for 5 minutes and respiratory parameters were measured and recorded for 10 minutes by the manufacturer's software (Buxco FinePointe). Mean values for each parameter per mouse were used for analysis.

Whole lungs were removed at 24 hours after infection, placed in 1 ml cold PBS, and homogenized using a Tissue Tearor (Dremel 985370). 100 µl of serially diluted sample was plated on tryptic soy agar containing 5% sheep's blood (Remel R01200), and CFU were counted after overnight incubation at 37°C/5% CO 2 . 

RNA was extracted from homogenized lung tissue using the RNeasy Mini kit (Qiagen 74106) and reverse transcribed to cDNA (BioRad 1708891) following the manufacturers' protocols (49) . Equal quantities of cDNA were added to a Taqman master mix (Life Technologies 4304437) containing either Cxcl1 (ThermoFisher Mm04207460_m1), Cxcl2 (ThermoFisher Mm00436450_m1), Cxcl12 (ThermoFisher Mm00445553_m1), Ly6g (ThermoFisher Mm04934123_m1), Csf2 (ThermoFisher Mm01290062_m1) or Csf3 (Mm00438334_m1), and Gapdh as endogenous control (Thermo Fisher 4352339E). Real-time quantitative PCR was performed using the QuantStudio 3 Real-Time PCR System (ThermoFisher Scientific) and analyzed using the DDCt algorithm (50).

Blood was collected from mice via cardiac puncture immediately following euthanasia and allowed to coagulate for 30 minutes before serum separation by centrifugation. Granulocyte-colony stimulating factor (G-CSF) was measured in serum samples according to manufacturer's protocol (R&D Systems DY414).

The left lung lobe was inflated with 10% formalin (Fisher SF98-4), fixed overnight, and kept in 70% ethanol until processing. Paraffinembedded tissue was sectioned (5 µm) and stained using hematoxylin and eosin (H&E) or IHC antibodies and scored in a blinded fashion by an experimental pathologist. IHC was performed using primary antibodies against Ly6G (1:250, BD Biosciences 551459) and S. pneumoniae (1:1000; Novus Biologicals NB100-64502), and detected using ImmPress polymer reagents (Vector Laboratories). Antigen expression was visualized with 3,3'Diaminobenzidine and alkaline phosphatase according to manufacturer's protocol (Vector Laboratories). Sections were counterstained with Hematoxylin QS and slides were coverslipped using VectaMount medium (Vector Laboratories).

Semi-quantitative assessment of the following injury criteria in the H&E-stained sections was performed: gross accumulations of inflammatory cells in the lung parenchyma (0-6), presence of leukocytes in the airways (0-2), peri-vascular inflammatory cell accumulation (0-2) or edema (0-2), and proteinaceous material in the alveolar space (0-2). Analysis of IHC staining intensity was achieved by capturing histologic images [enough 40x images per animal to completely cover the whole IHC-stained lung crosssection (5-8 per animal)] on an Olympus BX51 (Waltham, MA) microscope equipped with a 4 megapixel Macrofire digital camera using the PictureFrame Application 2.3 (Optronics, Goleta, CA). Images were then imported into Slidebook (3I, Denver, CO) for quantification. Data are expressed as percent IHC positive pixels (51) . Phagocytosis of S. pneumoniae was measured by capturing stitched images with a light microscope equipped with a motorized XY-stage at 400x magnification (Olympus IX83) and CellSens software (version 1.16, Olympus Life Sciences). Manual quantification of 8-9 non-overlapping 400x images per animal was performed and phagocytosis was calculated as the number of cells with internalized S. pneumoniae relative to total nucleated cells. Average percentage phagocytosis per group is presented.

Data were analyzed with Graph Pad Prism software for Windows version 9.2.0 (GraphPad Software, San Diego, California USA) using an unpaired two-tailed t test with Welch's correction or one-way ANOVA as appropriate and indicated in figure legends. p value < 0.05 was considered to represent a significant difference between treatment groups.

To test our hypothesis that ethanol exposure impairs clearance of S. pneumoniae from the lungs, we gavaged mice with vehicle (water) or ethanol (1.5 g/kg) and intra-nasally instilled S. pneumoniae or PBS ( Figure 1A ). This dose of ethanol raised serum BAC to approximately 80 mg/dL at 30 minutes postgavage ( Figure 1B) . Our results indicate that ethanol-exposed infected mice had significantly higher average S. pneumoniae CFU in whole lung homogenates at 24 hours post-infection ( Figure 1C) . Importantly, since we are introducing 10 4 CFU S. pneumoniae via an intra-nasal route (vs. direct administration of bacteria to the lungs via an intra-tracheal infection), our results confirm that the bacteria are able to withstand the initial immune response in the upper respiratory tract to reach the lungs, establish an infection, and begin to replicate. Ethanol-Exposed Mice Have Impaired Respiratory Function After S. pneumoniae Infection Compared to Vehicle-Exposed Animals

To determine the effect of ethanol consumption on respiratory function in our infected animals, we performed unrestrained whole-body plethysmography prior to infection and up to 7 days after infection. Here, we report respiratory rate [breaths per minute (bpm)], enhanced pause ratio (penh)a dimensionless index of airflow patterns as a mouse breathes (43) , expiration time (Te), and Rpefthe time required to reach peak expiratory flow relative to Te (44) . Before infection, all parameters were similar between our vehicle-and ethanol-exposed groups; therefore, we used vehicle-exposed uninfected animals as our control group throughout the 7-day time course (Figure 2A-D) . When comparing respiratory parameters between infected groups, we noted a significantly higher penh value in our ethanol-compared to vehicle-exposed infected mice from days 1-4 post-infection (Figure 2A) , decreased breathing frequency in the ethanol-exposed infected animals at 24 hours ( Figure 2B ), increased expiratory time in ethanol-exposed animals at 24 hours ( Figure 2C) , and a lower Rpef value in ethanol-compared to vehicle-exposed infected mice at 24 hours ( Figure 2D) . Notably, penh values in the vehicle-exposed infected mice did not differ from the uninfected mice through 7 days of infection ( Figure 2A ).

Since our initial results showed that ethanol administration is associated with increased pulmonary bacterial burden and impaired respiratory function at 24 hours, we wondered if this was due to ineffective trafficking of immune cells to the infection site at this time point. To test this, we used flow cytometry to quantify neutrophils and macrophages, important early responders to S. pneumoniae infection, in single cell suspensions of whole lung homogenates. We identified neutrophils as CD45 + CD11b + Ly6G hi , and distinguished tissue-resident alveolar macrophages from infiltrating macrophages based on SiglecF and CD11b expression ( Figure 3A) . Alveolar macrophages are designated as CD45 + F4/ 80 + SiglecF + CD11b neg/dim , while infiltrating macrophages are CD45 + F4/80 + SiglecF neg/dim CD11b + (45) . The number of cells in these subsets did not differ in our uninfected mice based on vehicle or ethanol treatment ( Figure 3B ). However, we found increased numbers of neutrophils in both infected groups relative to uninfected animals at 24 hours ( Figure 3B) , indicative of an innate immune response to the infection. When comparing vehicle-exposed infected animals to their ethanol-exposed counterparts, we found that ethanol exposure resulted in 1.8-fold more neutrophils in the lungs of infected animals at 24 hours but noted no difference in the number of alveolar or infiltrating macrophages ( Figure 3B) . Finally, to complement our result of increased neutrophils in the lungs of ethanol-exposed animals after infection, we performed quantitative PCR on whole lung homogenates for Ly6g expression. We observed 5.0-and 2.7-fold higher Ly6g transcript in lung homogenates of ethanol-exposed infected animals compared to uninfected animals or vehicleexposed infected animals, respectively ( Figure 3C) . Based on our results showing an increased number of lung neutrophils in ethanol-exposed infected animals observed by flow cytometry, we evaluated pulmonary expression of the chemokine genes Cxcl1, Cxcl2, and Cxcl12, important neutrophil chemoattractants and activators produced during the inflammatory response to infection (26, 46) . Additionally, we measured pulmonary expression of Csf2 and Csf3, the genes encoding for granulocyte macrophage-colony stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF), respectively, important cytokines for inducing granulopoiesis and the release of granulocytes from the bone marrow (47), along with serum levels of G-CSF. Our data show that, compared to vehicle-exposed infected animals, the ethanol-exposed infected mice had significantly higher expression of Cxcl1 (3.0fold) and Cxcl2 (3.7-fold), and no difference in Cxcl12, in lung homogenates at 24 hours ( Figure 4A ). Further, we found no difference in Csf2 expression, but rather elevated levels of Csf3 transcript in the lung and G-CSF in the serum (17.2-fold and 3.0fold higher, respectively), in ethanol-compared to vehicleexposed infected animals ( Figures 4B, C) . We noted no difference in pulmonary gene expression or serum G-CSF levels between our vehicle-or ethanol-exposed uninfected groups ( Figure 4 ).

Due to the increased number of neutrophils in the lungs of ethanol-exposed infected animals detected by flow cytometry at 24 hours, we analyzed histological markers of inflammation and injury in H&E-stained lung sections. We found that ethanolexposed infected animals had significantly increased perivascular cell accumulation at 24 hours and a trend toward more leukocytes in the lumen of the larger airways compared to vehicle-exposed infected animals ( Figures 5A, B) . We failed to observe a difference in the other individual scoring criteriagross accumulation of inflammatory cells in the lung parenchyma, peri-vascular edema, or proteinaceous material in the alveolar space (data not shown). Next, since we noted altered leukocyte localization in the lungs by H&E and a difference in neutrophil numbers and transcript by flow cytometry and qPCR, respectively, we evaluated neutrophil and bacterial localization after infection utilizing IHC staining. Quantification of staining (as assessed by percent positive pixels) showed a great deal of variation between animals within groups, and thus, no statistical difference was observed in the levels of Ly6G or S. pneumoniae antigen in lung sections from our vehicleand ethanol-exposed infected animals (Supplementary Figure 1) . represent values from infected animals (except for the "pre" values, which were obtained in vehicle-and ethanol-exposed mice prior to infection). Data are presented as mean ± SEM. n = 3-6 mice per group per experiment and data are combined from 3 individual experiments. *p < 0.05 compared to vehicle-exposed infected animals, #p < 0.05 compared to uninfected animals by one-way ANOVA.

We noted an increased presence of neutrophils in the infected groups compared to vehicle-exposed uninfected animals (Supplementary Figure 1) , with neutrophil localization near S. pneumoniae in both infected groups ( Figure 6 ). Additionally, we observed a 4.6-fold higher percentage of internalized S. pneumoniae in macrophages of vehicle-compared to ethanolexposed infected animals ( Figure 6 ).

Excessive alcohol consumption weakens the ability of the immune system to effectively respond to pathogens (52) . Here, we describe those 3 consecutive days of a more moderate ethanol exposure than what is typically used in the literature ( Figures 1A, B) can significantly alter the early pulmonary response to Streptococcus pneumoniae. Although the peak BAC in our studies is approximately 80 mg/dL, considered the "legal limit" for driving in humans, it is likely that the BAC levels for intoxication in mice are comparably lower due to increased metabolism of ethanol in rodents compared to humans (53) . Nonetheless, we found that ethanol exposure increases bacterial burden in the lung and decreases respiratory function within 24 hours after S. pneumoniae infection ( Figures 1C, 2) . Our results showing increased bacterial burden in the lungs of ethanol-exposed mice ( Figure 1C ) is in line with previous studies utilizing pathogens such as S. pneumoniae (54), Klebsiella pneumoniae (55, 56) , and Escherichia coli (57) . However, the animal models in these studies use supra-physiological levels of acute ethanol (often enough to raise BAC well above 350 mg/dL) or binge-on-chronic ethanol feeding [Lieber-DeCarli diet (58) for a total of 10 days with a 4 g/kg ethanol gavage on days 5 and 10 (55, 56)] before infection, making it challenging to directly compare results. Even so, our work expands upon previous findings by showing a similar response of increased bacterial burden in animals exposed to a much lower and shorter threeday ethanol exposure regimen (1.5 g/kg) and infected with a lower S. pneumoniae inoculum (10 4 CFU). We believe that our model better recapitulates how humans who drink alcohol may acquire bacterial pneumonia via respiratory droplets, as our mice are given an oral gavage of ethanol at a more moderate level and then infected intranasally. Furthermore, humans tend to drink alcohol for social motives (59) putting them in close proximity to others who may be infected, or more commonly, those who are asymptomatic carriers of S. pneumoniae (60) . Previous studies have found that respiratory disease is associated with impaired lung function using whole body plethysmography, including pneumococcal (61) and SARS-CoV2 infection (62) , and bleomycin-induced lung injury (63) . Further, our group has shown that multi-day ethanol exposure leads to respiratory dysfunction following traumatic injury, such as a cutaneous scald (16, 64) . The increased penh values suggest altered airflow patterns in response to airway inflammation (65, 66) , while the higher expiratory time and corresponding decreased Rpef values suggest airway narrowing/obstruction (67, 68) and airway collapse with increased airflow resistance (69, 70) in ethanol-compared to vehicle-exposed infected mice. Increased leukocyte accumulation, pulmonary edema, and alveolar wall thickening observed histologically ( Figure 5A ; Supplementary Figure 2 ) likely contribute to the impaired respiratory function observed by plethysmography. One caveat to our lung function data is that we observed mortality during the studies so respiratory parameters are representative of surviving animals only. On day 4, 6% and 14% of the vehicleand ethanol-exposed infected animals, respectively, died. An additional 12% and 8%, respectively, of the remaining animals died on day 5; we did not observe any further mortality through day 7 post-infection (data not shown). Nevertheless, our study is the first to our knowledge that demonstrates an effect of multiday lower-dose ethanol exposure on respiratory parameters following S. pneumoniae infection.

Neutrophils are critical early responders to respiratory pathogens, but their presence and activity at infection sites can be detrimental if not properly controlled. Using several different pathogens, animal studies have demonstrated that the host is more susceptible to severe pneumonia and death when neutrophils are depleted or otherwise unable to reach the lung (36, 71) , but also when excessive neutrophil accumulation and their ineffective clearance leads to tissue damage (72) (73) (74) (75) . Our results show that ethanol-exposed mice had a higher pulmonary bacterial burden at 24 hours after infection ( Figure 1C ) despite increased numbers of pulmonary neutrophils ( Figure 3B ) and correspondingly higher expression of chemokines involved in neutrophil recruitment, such as Cxcl1 and Cxcl2 ( Figure 4A) . Likewise, the upregulation of Csf3 in the lungs and increased levels of G-CSF in the serum of ethanol-exposed infected mice ( Figures 4B, C) further suggests an immune response geared toward granulopoiesis and neutrophil homing to the lung. Indeed, others have shown that G-CSF mRNA levels are markedly increased in lung tissue from animals challenged intratracheally with E. coli but did not observe appreciable levels of G-CSF mRNA in spleen, liver, or kidney tissue from the same animals (76) . This suggests that the lung is a primary source of G-CSF production early after pulmonary infection. Previous work from our lab has shown that prior ethanol exposure leads to excessive accumulation of neutrophils (77, 78) and apoptotic cells (78) in the lungs of mice up to 24 hours following burn injury, compared to vehicle-treated injured mice. Although not directly tested in these studies, others have shown that ethanol exposure decreases phagocytic capacity in both alveolar macrophages (14, 15, (79) (80) (81) and neutrophils (82) (83) (84) , along with decreased efferocytosis by alveolar macrophages (17) . Our results showing increased bacterial burden in the lung despite higher numbers of neutrophils may suggest that either the tissue-resident alveolar macrophages or the infiltrating neutrophils are less efficient at properly phagocytosing and/or breaking down S. pneumoniae within the first 24 hours after infection. Our IHC staining of infected lung tissue would suggest the former (Figure 6 ), although we cannot rule out that the recruited neutrophils are also functionally impaired. Additionally, the presence of Ly6G-negative airway cells could indicate apoptotic macrophages that were not detected by flow cytometry. It is also possible that ethanol treatment in our mice indirectly alters neutrophil apoptosis due to the hyperinflammatory lung microenvironment following infection (85) and/or impairs efferocytosis of apoptotic neutrophils by alveolar macrophages or infiltrating macrophages; this question merits further evaluation and clarification. Indeed, others have reported delayed neutrophil apoptosis after acute ethanol exposure followed by a "second hit" to the immune system (86, 87) . It has been shown that blood neutrophils from ethanol-exposed burned animals had decreased expression of pro-apoptotic proteins such as caspase-3 and Bax, and correspondingly decreased apoptosis as measured by histone-associated DNA fragments (86) . Further, delayed neutrophil death appears to be a common characteristic of human inflammatory lung diseases such as cystic fibrosis, pneumonia, and idiopathic fibrosis, as well as in cancer with associated neutrophilia (87) . Importantly, in our model, if recruited pulmonary neutrophils are not able to properly die via apoptosis and be cleared by alveolar macrophages, they may undergo secondary necrosis, releasing toxic mediators such as elastase and reactive oxygen species, and inducing lung damage in our ethanol-exposed animals (88, 89) .

Inflammation is a necessary process to restore homeostasis after infection. Resident immune cells in the upper and lower respiratory tract detect pathogen associated molecular patterns on invading microorganisms and initiate a signaling cascade leading to mobilization and migration of leukocytes to the site of infection. The lungs of our infected animals showed an early accumulation of peri-vascular and airway leukocytes in animals with prior ethanol exposure (Figures 4A, B) . This suggests that recruited immune cells are able to reach the lungs but appear to be less efficient at clearance of S. pneumoniae as noted by CFU counts at 24 hours post-infection in our ethanol-exposed mice ( Figure 1C ). While we failed to see differences in the number of alveolar or infiltrating macrophages in lung homogenates by flow cytometry (Figure 3) , it is possible that ethanol exposure impairs monocyte trafficking to the lung, as others have previously shown (90) . Immunohistochemistry staining of lung sections provided valuable insight into the effect of ethanol on neutrophil and bacterial antigen localization, as well as bacterial internalization, following S. pneumoniae infection. We did not observe any gross difference in neutrophil proximity to S. pneumoniae, suggesting that neutrophils are able to migrate toward the infection site at 24 hours post-infection in our model. However, it is possible that neutrophil chemotaxis is impaired at earlier or later time points post-infection, or in other areas of the lung. Further, there was no significant difference in neutrophil or bacterial antigen staining intensity ( Supplementary Figure 1) , however, we are careful not to rely solely on this result since the quantification is from a single tissue section from each animal. Additionally, the S. pneumoniae antibody used for IHC is a whole cell serotype blend and will therefore bind to viable and non-viable bacteria and also closely related bacterial species; therefore, quantification of S. pneumoniae antigen by IHC may not directly relate to CFU counts of viable bacteria from lung homogenates.

The results presented here require further clarification in future studies. A strength of this work is the demonstration of increased neutrophils and S. pneumoniae in whole lung homogenates of ethanol-exposed infected animals at 24 hours, and visualization of the localization of each within the lung. In future experiments, we will characterize the number and functional capacity of neutrophil and macrophage populations in the airways following infection by isolation of these cells from BAL fluid (91) . Advanced flow cytometry analysis of blood, BAL fluid, and whole lung homogenates will identify the changing inflammatory cell populations and discriminate cell death (apoptosis or necrosis) in each. Additionally, it would be useful to determine which subset of pulmonary cells are expressing Cxcl1, Cxcl2 and Csf3, as this may yield a focused therapeutic target to improve health outcomes in alcohol consumers with pneumococcal pneumonia. Finally, because S. pneumoniae was still present in the lungs at 24 hours post-infection, it is imperative to examine the later innate and subsequent adaptive immune response in our model and determine whether complete resolution of the infection is altered due to ethanol exposure.

In summary, we show here that ethanol exposure-at a dose relevant to human consumption-results in higher lung bacterial burden despite an increased presence of pulmonary neutrophils following intranasal S. pneumoniae infection. An accumulation of leukocytes was visualized in the airways and peri-vascular space, and likely contributes to the respiratory dysfunction seen in our infected animals. Additionally, we noted differences in S. pneumoniae internalization in macrophages from our ethanolexposed infected animals, which likely contributes to the increased inflammation noted in our mice and could lead to delayed resolution of the infection. Taken together, these findings contribute to our knowledge of how short-term ethanol consumption at physiological doses can alter pulmonary immunity to respiratory infection. Future studies aimed at understanding the mechanisms underlying this exacerbated neutrophilic response could improve health outcomes in pneumonia patients who drink alcohol.

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

The animal study was reviewed and approved by IACUC University of Colorado Anschutz Medical Campus.

HH and KN designed and carried out the experiments. HH analyzed the data and wrote the manuscript. RM provided guidance on study design, and analyzing and interpreting flow cytometry data. DB provided critical input on experimental strategy and panel design for the flow cytometry experiments. DO blindly scored the H&E sections and provided interpretation of the lung histology. EK supervised the project. All authors provided feedback on results and critically reviewed the manuscript. All authors contributed to the article and approved the submitted version. 

Substance Abuse and Mental Health Services Administration. 2020 NSDUH Detailed Tables 2021

Alcohol Sales During the COVID-19 Pandemic 2021

Alcohol-Related Deaths During the COVID-19 Pandemic

Understanding Alcohol Use Disorder 2021

Moderate Wine and Alcohol Consumption: Beneficial Effects on Cardiovascular Disease

Effects of Moderate Alcohol Consumption on Inflammatory Biomarkers

Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults

Alcohol Consumption, Heavy Drinking, and Mortality: Rethinking the J-Shaped Curve

Invasive Aspergillosis in Patients With Severe Alcoholic Hepatitis

Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA

In Vivo Ethanol Exposure Down-Regulates TLR2-, TLR4-, and TLR9-Mediated Macrophage Inflammatory Response by Limiting P38 and ERK1/2 Activation

Ethanol Suppresses Phagosomal Adhesion Maturation, Rac Activation, and Subsequent Actin Polymerization During Fcgr-Mediated Phagocytosis

Acute Ethanol Exposure Attenuates Pattern Recognition Receptor Activated Macrophage Functions

Impaired Respiratory Function and Heightened Pulmonary Inflammation in Episodic Binge Ethanol Intoxication and Burn Injury

Acute and Chronic Alcohol Exposure Impair the Phagocytosis of Apoptotic Cells and Enhance the Pulmonary Inflammatory Response

Chronic Ethanol Consumption Compromises Neutrophil Function in Acute Pulmonary Aspergillus Fumigatus Infection

Diminished Neutrophil Extracellular Trap (NET) Formation is a Novel Innate Immune Deficiency Induced by Acute Ethanol Exposure in Polymicrobial Sepsis, Which can be Rescued by CXCL1

Alcohol's Effects on Lung Health and Immunity

Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia

Alcohol Consumption as a Risk Factor for Pneumonia: A Systematic Review and Meta-Analysis

Alcohol and the Risk of Pneumonia: A Systematic Review and Meta-Analysis

Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia

Influence of Pneumococcal Serotype Group on Outcome in Adults With Bacteraemic Pneumonia

Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung

Recognition of Streptococcus Pneumoniae by the Innate Immune System

Monocytes are Potent Facilitators of Alveolar Neutrophil Emigration During Lung Inflammation: Role of the CCL2-CCR2 Axis

Role of the SDF-1/ CXCR4 Axis in the Pathogenesis of Lung Injury and Fibrosis

The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish

A Promising Target in Inflammation and Autoimmunity. Immunotarg Ther

A Key Regulator of Neutrophil Production

Therapeutic Use of Cytokines to Modulate Phagocyte Function for the Treatment of Infectious Diseases: Current Status of Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Interferon-g

Regulation of Systemic and Local Neutrophil Responses by G-CSF During Pulmonary Pseudomonas Aeruginosa Infection

The Importance of Neutrophils in Resistance to Pneumococcal Pneumonia in Adult and Neonatal Mice

Macrophage Turnover Kinetics in the Lungs of Mice Infected With Streptococcus Pneumoniae

Monocyte Recruitment Into the Lungs in Pneumococcal Pneumonia

Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis

Acute Alcohol Intoxication Suppresses the Interleukin 23 Response to Klebsiella Pneumoniae Infection

Acute Alcohol Intoxication Suppresses the Pulmonary ELR-Negative CXC Chemokine Response to Lipopolysaccharide

Acute Ethanol Intoxication Suppresses Lung Chemokine Production Following Infection With Streptococcus Pneumoniae

Acute Alcohol Intoxication Impairs the Hematopoietic Precursor Cell Response to Pneumococcal Pneumonia

Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield With New Diagnostic Methods

Circadian Dependence of Corticosterone Release to Light Exposure in the Rat

Intoxication by Intraperitoneal Injection or Oral Gavage Equally Potentiates Postburn Organ Damage and Inflammation

Characterization of Inflammatory Responses During Intranasal Colonization With Streptococcus Pneumoniae

Measuring Respiratory Function in Mice Using Unrestrained Whole-Body Plethysmography

Mesenchymal Stem Cell Treatment Attenuates Liver and Lung Inflammation After Ethanol Intoxication and Burn Injury

Analyzing Real-Time PCR Data by the Comparative CT Method

Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine Acetylation

Focus on: Alcohol and the Immune System

Blood Ethanol Concentration Profiles: A Comparison Between Rats and Mice

Ethanol Impairs Mucosal Immunity Against Streptococcus Pneumoniae Infection by Disrupting Interleukin 17 Gene Expression

Alcohol-Associated Intestinal Dysbiosis Impairs Pulmonary Host Defense Against Klebsiella Pneumoniae

Pulmonary Immune Cell Trafficking Promotes Host Defense Against Alcohol-Associated Klebsiella Pneumonia

Suppression of the Granulocyte Colony-Stimulating Factor Response to Escherichia Coli Challenge by Alcohol Intoxication

The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease

Why do Young People Drink? A Review of Drinking Motives

Plethysmography for the Assessment of Pneumococcal Pneumonia and Passive Immunotherapy in a Mouse Model

New Metrics for Evaluating Viral Respiratory Pathogenesis

Assessment of Respiratory Physiology of C57BL/6 Mice Following Bleomycin Administration Using Barometric Plethysmography

Effects of Multiday Ethanol Intoxication on Postburn Inflammation, Lung Function, and Alveolar Macrophage Phenotype

Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric Plethysmography

Measurement of Airway Function Using Invasive and Non-Invasive Methods in Mild and Severe Models for Allergic Airway Inflammation in Mice

Forced Expiratory Time: A Composite of Airway Narrowing and Airway Closure

Role of Forced Expiratory Time in Identifying Airway Obstruction and Systematic Review of English Literature

Serial Histopathological Examination of the Lungs of Mice Infected With Influenza A Virus PR8 Strain

Elevated Cytokine and Chemokine Levels and Prolonged Pulmonary Airflow Resistance in a Murine Mycoplasma Pneumoniae Pneumonia Model: A Microbiologic, Histologic, Immunologic, and Respiratory Plethysmographic Profile

Chemokine-Dependent Neutrophil Recruitment in a Murine Model of Legionella Pneumonia: Potential Role of Neutrophils as Immunoregulatory Cells

Extracellular Adenosine Protects Against Streptococcus Pneumoniae Lung Infection by Regulating Pulmonary Neutrophil Recruitment

Toll/ IL-1R Domain-Containing Adaptor Protein (TIRAP) Is a Critical Mediator of Antibacterial Defense In the Lung Against Klebsiella Pneumoniae But Not Pseudomonas Aeruginosa

Contribution of Neutrophils to Acute Lung Injury

Understanding the Roles of Cytokines and Neutrophil Activity and Neutrophil Apoptosis in the Protective Versus Deleterious Inflammatory Response in Pneumonia

The Granulocyte Colony-Stimulating Factor Response After Intrapulmonary and Systemic Bacterial Challenges

Elevation in Pulmonary Neutrophils and Prolonged Production of Pulmonary Macrophage Inflammatory Protein-2 After Burn Injury With Prior Alcohol Exposure

Ethanol Intoxication Prolongs Post-Burn Pulmonary Inflammation: Role of Alveolar Macrophages

Chronic Ethanol Ingestion in Rats Decreases Granulocyte-Macrophage Colony-Stimulating Factor Receptor Expression and Downstream Signaling in the Alveolar Macrophage

Alcoholism Causes Alveolar Macrophage Zinc Deficiency and Immune Dysfunction

Macrophage Phagocytosis: Effects of Environmental Pollutants, Alcohol, Cigarette Smoke, and Other External Factors

Acute Ethanol Intoxication Inhibits Neutrophil b2-Integrin Expression in Rats During Endotoxemia

Acute Ethanol Intoxication Suppresses the Pulmonary Inflammatory Response in Rats Challenged With Intrapulmonary Endotoxin

Alcohol Enhances Acinetobacter Baumannii-Associated Pneumonia and Systemic Dissemination by Impairing Neutrophil Antimicrobial Activity in a Murine Model of Infection

Neutrophil Apoptosis: Relevance to the Innate Immune Response and Inflammatory Disease

Interleukin-18 Delays Neutrophil Apoptosis Following Alcohol Intoxication and Burn Injury

Cytokine-Mediated Bax Deficiency and Consequent Delayed Neutrophil Apoptosis: A General Mechanism to Accumulate Effector Cells in Inflammation

Direct Evidence of Secondary Necrosis of Neutrophils During Intense Lung Inflammation

Neutrophil Elastase Causes Tissue Damage That Decreases Host Tolerance to Lung Infection With Burkholderia Species

Drinking Modulates Monocyte Migration in Healthy Subjects: A Randomised Intervention Study of Water, Ethanol, Red Wine and Beer With or Without Alcohol

Age-Related Differences in the Neutrophil Response to Pulmonary Pseudomonas Infection

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.